These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317 [TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215 [TBL] [Abstract][Full Text] [Related]
6. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Rättyä J; Turkka J; Pakarinen AJ; Knip M; Kotila MA; Lukkarinen O; Myllylä VV; Isojärvi JI Neurology; 2001 Jan; 56(1):31-6. PubMed ID: 11148232 [TBL] [Abstract][Full Text] [Related]
7. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity. Moreland TA; Park BK; Rylance GW Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885 [TBL] [Abstract][Full Text] [Related]
8. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations. Ahmad A; Garnett WR Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654 [TBL] [Abstract][Full Text] [Related]
9. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Isojärvi JI; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV Epilepsia; 1994; 35(6):1217-20. PubMed ID: 7988514 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers. Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485 [TBL] [Abstract][Full Text] [Related]
12. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. Connell JM; Rapeport WG; Gordon S; Brodie MJ Eur J Clin Pharmacol; 1984; 26(4):453-6. PubMed ID: 6428915 [TBL] [Abstract][Full Text] [Related]
13. Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements. Zaccara G; Gangemi PF; Messori A; Parigi A; Massi S; Valenza T; Monza GC Acta Neurol Scand; 1992 Jun; 85(6):425-9. PubMed ID: 1642114 [TBL] [Abstract][Full Text] [Related]
14. Changes in circulating androgens during short term carbamazepine therapy. Connell JM; Rapeport WG; Beastall GH; Brodie MJ Br J Clin Pharmacol; 1984 Mar; 17(3):347-51. PubMed ID: 6231939 [TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19. Lakehal F; Wurden CJ; Kalhorn TF; Levy RH Epilepsy Res; 2002 Dec; 52(2):79-83. PubMed ID: 12458024 [TBL] [Abstract][Full Text] [Related]
16. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers. Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Lloyd P; Flesch G; Dieterle W Epilepsia; 1994; 35 Suppl 3():S10-3. PubMed ID: 8156973 [TBL] [Abstract][Full Text] [Related]
18. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Schmidt D; Elger CE Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112 [TBL] [Abstract][Full Text] [Related]